1. 206 IMPACT OF TP53 MUTATION ON OUTCOME OF MDS PATIENTS UNDERGOING ALLOGENEIC STEM CELL TRANSPLANT (HSCT). GESMD STUDY. Issue 1 (April 2015) Authors: Campelo, M. Díez; Caballero, J.C.; Barba, M. Sánchez; Del Rey, M.; Janusz, K.; Lumbreras, E.; Abáigar, M.; Robledo, C.; Jerez, A.; Calderón-Cabrera, C.; Such, E.; Cervera, J.; Sanz, G.; Valcárcel, D.; Hernández-Rivas, J.M.; Del Cañizo, C. Journal: Leukemia research Issue: Volume 39:Issue 1(2015:Jan.) Page Start: S102 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 591. Continous Wound Catheters Delivering Levobupivacaine for Postoperative Analgesia in Children After Cardiac Surgery. (1st September 2008) Authors: Rubio, P.; Jerez, A.; Romero, M.; Mendez, D.; Notario, R. Journal: Regional anesthesia and pain medicine Issue: Volume 33(2008)Supplement 1 Page Start: e222 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. An increased percentage of myeloid CD34+ bone marrow cells stratifies intermediate IPSS‐R myelodysplastic syndrome patients into prognostically significant groups. (18th May 2018) Authors: Chen‐Liang, T.‐H.; Casado‐Prieto, A. M.; Campos‐Rodríguez, V.; Hurtado, A. M.; Amigo, M. L.; García‐Malo, M. D.; Vicente, V.; Ortuño, F. J.; Jerez, A. Journal: International journal of laboratory hematology Issue: Volume 40:Number 5(2018:Oct.) Page Start: 549 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Calculating IPSS-R by Enumerating Bone Marrow Blasts from Nonerythroid Cellularity Improves Outcome Prediction in MDS with Erythroid Predominance. (April 2017) Authors: Calvo, X.; Arenillas, L.; Luño, E.; Senent, L.; Arnan, M.; Ramos, F.; Pedro, C.; Tormo, M.; Montoro, J.; Diez-Campelo, M.; Blanco, M.L.; Arrizabalaga, B.; Xicoy, B.; Bonanad, S.; Jerez, A.; Nomdedeu, M.; Ferrer, A.; Sanz, G.; Florensa, L. Journal: Leukemia research Issue: Volume 55(2017)Supplement 1 Page Start: S137 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. DNA Repair Genes Transcriptome in Chronic Myelomonocytic Leukemia. (April 2017) Authors: Hurtado, A.M.; Luengo-Gil, G.; Chen-Liang, T.H.; Palomo, L.; Lumbreras, E.; Przychodzen, B.; Amigo, M.L.; Díez-Campelo, M.; Zamora, L.; Ortuño, F.; Vicente, V.; Maciejewski, J.; del Cañizo, C.; Solé, F.; Ferrer-Marín, F.; Jerez, A. Journal: Leukemia research Issue: Volume 55(2017)Supplement 1 Page Start: S100 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Donor Cell MDS with Rare Complex Karyotype After Mismatch Alobmt for Ph+ALL. (April 2017) Authors: Jerez, A.; Merino, M.; Buño, I.; Chen-Liang, T.-H.; Iniesta, P.; Garcia, A.; Teruel, R.; Amigo, M.L.; Alamo, J.M.; Suarez, J.; Ortuño, F.J.; Vicente, V. Journal: Leukemia research Issue: Volume 55(2017)Supplement 1 Page Start: S176 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Measurements and modeling of PAH soot precursors in coflow ethylene/air laminar diffusion flames. (15th January 2019) Authors: Jerez, A.; Cruz Villanueva, J.J.; Figueira da Silva, L.F.; Demarco, R.; Fuentes, A. Journal: Fuel Issue: Volume 236(2019) Page Start: 452 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. P1137: ACCURACY AND PROGNOSTIC IMPACT OF FDG PET/CT AND BIOPSY IN BONE MARROW ASSESSMENT OF FOLLICULAR LYMPHOMA AT DIAGNOSIS: A NATION-WIDE STUDY. (23rd June 2022) Authors: Ródenas Quiñonero, I.; Chen-Liang, T.; Martín-Santos, T.; Salar, A.; Fernández-González, M.; Celades, C.; Navarro, J. T.; Martinez, A. B.; Andreu, R.; Balaguer, A.; Martín, A.; Baile, M.; López-Jiménez, J.; Marquet, J.; Teruel, A. I.; Terol, M. J.; Benet, C.; Frutos, L.; Navarro, J. L.; Uña, J. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1027 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. P788: FACTORS DRIVING TREATMENT DECISION IN PATIENTS WITH INTERMEDIATE-RISK MYELODYSPLASTIC SYNDROME (MDS): A RETROSPECTIVE ANALYSIS FROM THE GRUPO ESPAÑOL DE SÍNDROMES MIELODISPLÁSICOS SPANISH MDS REGISTRY. (23rd June 2022) Authors: Díez-Campelo, M.; Hernandez-Donoso, L.; Sasse, E.; Colicino, S.; Curto, J.; Molero Yordi, A.; Tormo Díaz, M.; Arnan, M.; Sanz, G.; Díaz-Beyá, M.; Cedena Romero, M. T.; Jerez, A.; Valcárcel Ferreiras, D. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 683 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. PB1918: MOLECULAR CHARACTERIZATION AND CLINICAL RELEVANCE OF ERYTHROPOIESIS IN MIELODYSPLASTIC SYNDROMES. (23rd June 2022) Authors: Villalba, A.; Such, E.; Senent, L.; Mora, E.; Avetisyan, G.; Vicente, A. I.; Tormo, M.; Jerez, A.; Ramos, F.; Montoro, J.; Bernal, T.; lLuna, I.; Santiago, M.; Diaz, A.; Liquori, A.; Cervera, J.; Sanz, G. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1797 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗